OncoZenge AB (publ) 8LY.F Stock
OncoZenge AB (publ) Price Chart
OncoZenge AB (publ) 8LY.F Financial and Trading Overview
| OncoZenge AB (publ) stock price | 0.3 EUR |
| Previous Close | 0.54 EUR |
| Open | 0.53 EUR |
| Bid | 0.52 EUR x N/A |
| Ask | 0.54 EUR x N/A |
| Day's Range | 0.52 - 0.53 EUR |
| 52 Week Range | 0.18 - 0.87 EUR |
| Volume | 50 EUR |
| Avg. Volume | 256 EUR |
| Market Cap | 6.48M EUR |
| Beta (5Y Monthly) | 1.62949 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.12 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
8LY.F Valuation Measures
| Enterprise Value | 6.28M EUR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
OncoZenge AB (publ) Stock Price History
| Beta (5Y Monthly) | 1.62949 |
| 52-Week Change | 191.30% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.87 EUR |
| 52 Week Low | 0.18 EUR |
| 50-Day Moving Average | 0.66 EUR |
| 200-Day Moving Average | 0.49 EUR |
8LY.F Share Statistics
| Avg. Volume (3 month) | 256 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 11.71M |
| Float | 8.47M |
| Short Ratio | N/A |
| % Held by Insiders | 52.56% |
| % Held by Institutions | 1.47% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -22.76% |
| Return on Equity (ttm) | -39.46% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | -0.11 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 14.691 |
| Book Value Per Share (mrq) | N/A |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of OncoZenge AB (publ)
| Country | Germany |
| State | N/A |
| City | Bromma |
| Address | Gustavslundsvagen 34 |
| ZIP | 167 51 |
| Phone | 46 8 31 14 20 |
| Website | https://www.oncozenge.se |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
OncoZenge AB (publ), a pharmaceutical company, develops treatment for pain relief in patients suffering from oral pain caused by radiation therapy and chemotherapy for cancer in Sweden. It offers BupiZenge, which has completed Phase 2 clinical trial for the treatment of oral mucositis. The company was founded in 2020 and is headquartered in Bromma, Sweden.
Q&A For OncoZenge AB (publ) Stock
What is a current 8LY.F stock price?
OncoZenge AB (publ) 8LY.F stock price today per share is 0.3 EUR.
How to purchase OncoZenge AB (publ) stock?
You can buy 8LY.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for OncoZenge AB (publ)?
The stock symbol or ticker of OncoZenge AB (publ) is 8LY.F.
Which industry does the OncoZenge AB (publ) company belong to?
The OncoZenge AB (publ) industry is Biotechnology.
How many shares does OncoZenge AB (publ) have in circulation?
The max supply of OncoZenge AB (publ) shares is 12.27M.
What is OncoZenge AB (publ) Price to Earnings Ratio (PE Ratio)?
OncoZenge AB (publ) PE Ratio is now.
What was OncoZenge AB (publ) earnings per share over the trailing 12 months (TTM)?
OncoZenge AB (publ) EPS is -0.12 EUR over the trailing 12 months.
Which sector does the OncoZenge AB (publ) company belong to?
The OncoZenge AB (publ) sector is Healthcare.